HomeOpen Access NewsPharma

Pharma

Subscribe to Updates

Rapid test trial to diagnose winter respiratory infections in minutes

Pharma
NIHR-supported trial tests a rapid, low-cost point-of-care test that can diagnose flu, COVID‑19, and RSV in minutes, potentially speeding up winter diagnosis and care across the NHS.

Growing pains: Creating value in the maturing cannabis market

Pharma
Liam McGreevy, CEO of Ethnopharm Ltd, explains his thoughts on creating value in today’s maturing cannabis market, including how the firm can help both new and established businesses make sense of this.

Medical cannabis vaporizers

Pharma
Vatra Syla, Head of Marketing, Storz & Bickel GmbH & Co. KG, discusses the importance of medical cannabis vaporizers.

EU crackdown: Novel food regulation of CBD

Pharma
Here, European Union (EU) Novel Food regulations are thoroughly explored and questioned in the context of CBD in food.

Why patient advocates are key to growing CBD brands

Pharma
Here, we discuss how unregulated industry patient advocates are integral to strengthening the credibility of growing CBD brands.

Up in smoke: Understanding knowledge gaps for cannabis edibles

Pharma
Michael A. Rogers outlines four necessary elements to increase further societal understanding about the use of cannabis edibles.

The cultivation of sustainable and organic medical cannabis in controlled environments

Pharma
CEO of OC Care ApS, Christian Ohlendorff Hollensen, illuminates us on what we need to know about the cultivation of sustainable and organic medical cannabis in controlled environments, including the essential factor of lighting.

Sovereignport discuss their CBD and Hemp supply chain

Pharma
Speaking with Sarah Yetman, CEO of Sovereignport, we understand how she pioneered a CBD and hemp supply chain that is surviving COVID-19 measures.

Cannyx Markets UK Ltd: The globalisation of the CBD industry

Pharma
Here, Hassan Akhtar explains how Cannyx Markets UK Ltd. Are successfully navigating the globalisation of the CBD industry.

Professor Mike Barnes: The future of medical cannabis is real

Pharma
We spoke to Professor Mike Barnes, to discuss the future of medical cannabis and cut through the fake news saturating the field.

Cannabinoids in medicine part 4: Epilepsy

Pharma
In the fourth of a series of five articles, Oxford Cannabinoid Technologies discuss their expertise on cannabinoids in medicine.

Malta’s stance on cannabis for medicinal and research purposes

Pharma
Here, the Malta Medicines Authority (MMA) shares a vision which integrates regulatory sciences, innovation, and academic initiatives.

Setting global standards for CBD quality and compliance

Pharma
At Mile High Labs, we share a collective vision for global standards of CBD quality and compliance: Let’s discuss the Novel Food application process for the UK.

The FDA’s 2020 Cannabis policy

Pharma
Here, Ann Allworth discusses what lies ahead for the FDA’s 2020 Cannabis policy and highlights discrepancies in their thinking.

Standardised extracts are the future of the CBD industry

Pharma
Following the latest legislative and market trends, Ilesol Pharmaceuticals has developed a new product with a shiny future in the CBD industry.

Removing the barriers to ensure a thriving UK hemp industry

Pharma
Rebekah Shaman, Managing Director at British Hemp Alliance, explains what we need to know about removing the barriers to ensure a thriving UK hemp industry.

Cannabis (hemp): The effect of terpenes in CBD full extracts

Pharma
Cannabis (hemp) contains up to 150 different terpenes. They not only determine the smell, but they also have valuable properties for the body as studies show. Katharina Zedlacher, from BioBloom GmbH, discusses the effect of terpenes in CBD full extracts.
1...456Page 15 of 6

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders

Visit Article Archive
Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd